Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.

Literature DB >> 12682190

In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.

Martin Sicklinger¹, Ralf Wienecke, Uwe Neubert.

Abstract

MICs and minimal bactericidal concentrations (MBCs) were evaluated for the four antibiotics azithromycin, amoxicillin, ceftriaxone, and doxycycline against the three main genospecies of Borrelia burgdorferi sensu lato. In MBC testing, statistically significant differences between the genospecies could be found in 7 out of 12 comparative evaluations (P < 0.05).

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2003 PMID： 12682190 PMCID： PMC153919 DOI： 10.1128/JCM.41.4.1791-1793.2003

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

13 in total

Review 1. Aspects of Lyme borreliosis in Europe.

Authors: K Weber
Journal: Eur J Clin Microbiol Infect Dis Date: 2001-01 Impact factor: 3.267

2. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.

Authors: S Jaruratanasirikul; R Hortiwakul; T Tantisarasart; N Phuenpathom; S Tussanasunthornwong
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

3. Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.

Authors: D Janovská; D Hulínská; T Godová
Journal: Cent Eur J Public Health Date: 2001-02 Impact factor: 1.163

4. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.

Authors: K P Hunfeld; P Kraiczy; T A Wichelhaus; V Schäfer; V Brade
Journal: Int J Antimicrob Agents Date: 2000-06 Impact factor: 5.283

Review 5. Lyme disease.

Authors: A C Steere
Journal: N Engl J Med Date: 1989-08-31 Impact factor: 91.245

6. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors: G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal: Int J Syst Bacteriol Date: 1992-07

7. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.

Authors: V Preac Mursic; W Marget; U Busch; D Pleterski Rigler; S Hagl
Journal: Infection Date: 1996 Jan-Feb Impact factor: 3.553

8. In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.

Authors: J M Levin; J A Nelson; J Segreti; B Harrison; C A Benson; F Strle
Journal: Antimicrob Agents Chemother Date: 1993-07 Impact factor: 5.191

9. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.

Authors: R Wienecke; N Zöchling; U Neubert; E M Schlüpen; M Meurer; M Volkenandt
Journal: J Invest Dermatol Date: 1994-07 Impact factor: 8.551

10. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors: A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal: Clin Infect Dis Date: 1993-10 Impact factor: 9.079

18 in total

1. Functional analysis of Borrelia burgdorferi uvrA in DNA damage protection.

Authors: Mariya Sambir; Larisa B Ivanova; Anton V Bryksin; Henry P Godfrey; Felipe C Cabello
Journal: FEMS Microbiol Lett Date: 2011-02-17 Impact factor: 2.742

2. In Vitro Susceptibility of Treponema pallidum subsp. pallidum to Doxycycline.

Authors: Diane G Edmondson; Gary P Wormser; Steven J Norris
Journal: Antimicrob Agents Chemother Date: 2020-09-21 Impact factor: 5.191

3. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.

Authors: Klaus-Peter Hunfeld; Eva Ruzic-Sabljic; Douglas E Norris; Peter Kraiczy; Franc Strle
Journal: Antimicrob Agents Chemother Date: 2005-04 Impact factor: 5.191

4. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.

Authors: Michael R Mosel; Heather E Carolan; Alison W Rebman; Steven Castro; Christian Massire; David J Ecker; Mark J Soloski; John N Aucott; Mark W Eshoo
Journal: Antimicrob Agents Chemother Date: 2019-06-24 Impact factor: 5.191

5. Pharmacokinetic analysis of oral doxycycline in rhesus macaques.

Authors: Monica E Embers; Nicole R Hasenkampf; Dale G Embers; Lara A Doyle
Journal: J Med Primatol Date: 2012-12-20 Impact factor: 0.667

6. Generality of Post-Antimicrobial Treatment Persistence of Borrelia burgdorferi Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains.

Authors: Emir Hodzic; Denise M Imai; Edlin Escobar
Journal: Infect Immun Date: 2019-09-19 Impact factor: 3.441